103 related articles for article (PubMed ID: 10474251)
1. Antisense oligodeoxynucleotide complementary to CXCR4 mRNA block replication of HIV-1 in COS cells.
Kusunoki A; Wada A; Kurosaki N; Kimura T; Takai K; Yamamoto N; Takaku H
Nucleosides Nucleotides; 1999; 18(6-7):1705-8. PubMed ID: 10474251
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the human chemokine receptor CXCR4 by antisense phosphorothioate oligodeoxyribonucleotides.
Kusunoki A; Saitou T; Miyano-Kurosaki N; Takaku H
FEBS Lett; 2001 Jan; 488(1-2):64-8. PubMed ID: 11163797
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo transport and delivery of phosphorothioate oligonucleotides with cationic liposomes.
Miyano-Kurosaki N; Barnor JS; Takeuchi H; Owada T; Nakashima H; Yamamoto N; Matsuzaki T; Shimada F; Takaku H
Antivir Chem Chemother; 2004 Mar; 15(2):93-100. PubMed ID: 15185727
[TBL] [Abstract][Full Text] [Related]
4. Antisense phosphorothioate oligonucleotides targeted to the human chemokine receptor CXCR4.
Kusunoki A; Miyano-Kurosaki N; Kimura T; Takai K; Yamamoto N; Gushima H; Takaku H
Nucleosides Nucleotides Nucleic Acids; 2000; 19(10-12):1709-19. PubMed ID: 11200267
[TBL] [Abstract][Full Text] [Related]
5. Antisense oligodeoxynucleotide phosphorothioate complementary to Gag mRNA blocks replication of human immunodeficiency virus type 1 in human peripheral blood cells.
Lisziewicz J; Sun D; Weichold FF; Thierry AR; Lusso P; Tang J; Gallo RC; Agrawal S
Proc Natl Acad Sci U S A; 1994 Aug; 91(17):7942-6. PubMed ID: 8058738
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of HIV-1 replication in cultured cells with antisense oligonucleotides encapsulated in immunoliposomes.
Zelphati O; Zon G; Leserman L
Antisense Res Dev; 1993; 3(4):323-38. PubMed ID: 8155974
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of HIV-1 replication by a new type of circular dumbbell RNA/DNA chimeric oligonucleotides.
Park WS; Miyano-Kurosaki N; Abe T; Takai K; Yamamoto N; Takaku H
Biochem Biophys Res Commun; 2000 Apr; 270(3):953-60. PubMed ID: 10772932
[TBL] [Abstract][Full Text] [Related]
8. Sequence-specific inhibition of gene expression by a novel antisense oligodeoxynucleotide phosphorothioate directed against a nonregulatory region of the human immunodeficiency virus type 1 genome.
Anazodo MI; Wainberg MA; Friesen AD; Wright JA
J Virol; 1995 Mar; 69(3):1794-801. PubMed ID: 7853519
[TBL] [Abstract][Full Text] [Related]
9. Hairpin antisense oligonucleotides containing 2'-methoxynucleosides with base-pairing in the stem region at the 3'-end: penetration, localization, and Anti-HIV activity.
Kuwasaki T; Hosono K; Takai K; Ushijima K; Nakashima H; Saito T; Yamamoto N; Takaku H
Biochem Biophys Res Commun; 1996 Nov; 228(2):623-31. PubMed ID: 8920960
[TBL] [Abstract][Full Text] [Related]
10. Antisense oligonucleotides in solution or encapsulated in immunoliposomes inhibit replication of HIV-1 by several different mechanisms.
Zelphati O; Imbach JL; Signoret N; Zon G; Rayner B; Leserman L
Nucleic Acids Res; 1994 Oct; 22(20):4307-14. PubMed ID: 7524038
[TBL] [Abstract][Full Text] [Related]
11. [Inhibition of reproduction of the human immunodeficiency virus by sense and antisense oligodeoxynucleotides].
Pokrovskiĭ AG; Pliasunova OA; Blinov VM; Vlasov VV; Svinarchuk FP; Abramova TV; Gorn VV; Konevets DA
Mol Biol (Mosk); 1993; 27(5):1039-43. PubMed ID: 8246927
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of CXCR4 expression in MT4 cells by a recombinant vector expressing antisense RNA to CXCR4 and its potential anti-HIV-1 effect.
Xing HC; Xu XY; Liu Z; Wang QH; Yu M; Si CW
Jpn J Infect Dis; 2004 Jun; 57(3):91-6. PubMed ID: 15218216
[TBL] [Abstract][Full Text] [Related]
13. Long-term treatment of human immunodeficiency virus-infected cells with antisense oligonucleotide phosphorothioates.
Lisziewicz J; Sun D; Metelev V; Zamecnik P; Gallo RC; Agrawal S
Proc Natl Acad Sci U S A; 1993 May; 90(9):3860-4. PubMed ID: 8483903
[TBL] [Abstract][Full Text] [Related]
14. Specific inhibition of human immunodeficiency virus type 1 replication by antisense oligonucleotides: an in vitro model for treatment.
Lisziewicz J; Sun D; Klotman M; Agrawal S; Zamecnik P; Gallo R
Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11209-13. PubMed ID: 1454800
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of HIV-1 replication by triple-helix-forming phosphorothioate oligonucleotides targeted to the polypurine tract.
Tsukahara S; Suzuki J; Hiratou T; Takai K; Koyanagi Y; Yamamoto N; Takaku H
Biochem Biophys Res Commun; 1997 Apr; 233(3):742-7. PubMed ID: 9168925
[TBL] [Abstract][Full Text] [Related]
16. The multiple inhibitory mechanisms of GEM 91, a gag antisense phosphorothioate oligonucleotide, for human immunodeficiency virus type 1.
Yamaguchi K; Papp B; Zhang D; Ali AN; Agrawal S; Byrn RA
AIDS Res Hum Retroviruses; 1997 May; 13(7):545-54. PubMed ID: 9135872
[TBL] [Abstract][Full Text] [Related]
17. Sequence-specific RNase H cleavage of gag mRNA from HIV-1 infected cells by an antisense oligonucleotide in vitro.
Veal GJ; Agrawal S; Byrn RA
Nucleic Acids Res; 1998 Dec; 26(24):5670-5. PubMed ID: 9837998
[TBL] [Abstract][Full Text] [Related]
18. Antiviral effect of phosphorothioate oligodeoxyribonucleotides complementary to human immunodeficiency virus.
Kim SG; Hatta T; Tsukahara S; Nakashima H; Yamamoto N; Shoji Y; Takai K; Takaku H
Bioorg Med Chem; 1995 Jan; 3(1):49-54. PubMed ID: 8612046
[TBL] [Abstract][Full Text] [Related]
19. GEM 91--an antisense oligonucleotide phosphorothioate as a therapeutic agent for AIDS.
Agrawal S; Tang JY
Antisense Res Dev; 1992; 2(4):261-6. PubMed ID: 1363378
[No Abstract] [Full Text] [Related]
20. Mixed-backbone oligonucleotides as second generation antisense oligonucleotides: in vitro and in vivo studies.
Agrawal S; Jiang Z; Zhao Q; Shaw D; Cai Q; Roskey A; Channavajjala L; Saxinger C; Zhang R
Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2620-5. PubMed ID: 9122245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
